ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

25,807Medicare Part D Prescriptions Filled, Including Refills

Rank: 30 out of 780

$1.13M Total Retail Price of All Prescriptions

Rank: 47 out of 780

731 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
56% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 731 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

23% of this provider’s 731 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

2% of this provider’s 22,343 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

35 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
HYDROCODONE-ACETAMINOPHEN 1,159 947 S3 1 1
FUROSEMIDE 849 770 2 7
LEVOTHYROXINE SODIUM 791 723 3 5
CITALOPRAM HBR 664 597 4 23
AMLODIPINE BESYLATE 658 616 5 4
SIMVASTATIN 652 604 6 2
OMEPRAZOLE 590 516 7 3
POTASSIUM CHLORIDE 575 514 8 11
DONEPEZIL HCL 542 521 9 31
LISINOPRIL 515 504 10 6
TRAMADOL HCL 447 389 11 15
WARFARIN SODIUM 436 412 12 24
TRAZODONE HCL 430 381 13 35
PANTOPRAZOLE SODIUM 396 362 14 25
METOPROLOL TARTRATE 394 367 15 19
ATENOLOL 327 283 16 21
MELOXICAM 322 250 17 16
METFORMIN HCL 319 283 18 8
GABAPENTIN 284 223 19 13
POLYETHYLENE GLYCOL 3350 272 248 20 79
TRIAMTERENE-HCTZ 265 209 21 37
TAMSULOSIN HCL 260 226 22 36
MIRTAZAPINE 258 253 23 58
NAMENDA 255 255 24 46
METOPROLOL SUCCINATE 248 232 25 20
QUETIAPINE FUMARATE 246 241 26 81
ZOLPIDEM TARTRATE 245 183 27 17
CARVEDILOL 231 193 28 14
ATORVASTATIN CALCIUM 227 202 29 12
RISPERIDONE 209 209 30 98
PRAVASTATIN SODIUM 209 185 30 9
LOVASTATIN 206 157 32 47
LOSARTAN POTASSIUM 201 168 33 18
ESCITALOPRAM OXALATE 197 158 34 61
SERTRALINE HCL 188 172 35 27
NEXIUM 187 116 36 22
CLONIDINE HCL 172 141 37 28
GLIMEPIRIDE 163 144 38 30
FENTANYL 159 145 S2 39 107
LYRICA 157 124 40 52
DOXYCYCLINE HYCLATE 155 121 41 103
CLOPIDOGREL 146 134 42 34
CYMBALTA 144 110 43 51
SEROQUEL 135 127 44 172
CIPROFLOXACIN HCL 130 117 45 49
LANTUS 122 89 46 71
PLAVIX 117 111 47 45
ENALAPRIL MALEATE 115 111 48 64
OXYCODONE-ACETAMINOPHEN 115 104 S2 48 187
DOXAZOSIN MESYLATE 112 106 50 97
HYDROCHLOROTHIAZIDE 111 96 51 10
METHOCARBAMOL 111 86 R 51 84
AZITHROMYCIN 110 95 53 38
ALLOPURINOL 107 87 54 29
METOCLOPRAMIDE HCL 106 90 55 102
BACLOFEN 106 75 55 153
ALENDRONATE SODIUM 104 92 57 44
MECLIZINE HCL 102 92 58 83
DIOVAN 101 101 59 55
LISINOPRIL-HYDROCHLOROTHIAZIDE 100 73 60 26
PREDNISONE 98 97 61 40
LOSARTAN-HYDROCHLOROTHIAZIDE 98 76 61 33
FAMOTIDINE 96 88 63 86
CRESTOR 95 86 64 32
CELEBREX 94 64 65 89
OXYBUTYNIN CHLORIDE 94 94 65 148
DIGOXIN 92 83 67 56
HUMULIN R 91 89 68 228
PROAIR HFA 91 56 68 62
HYDRALAZINE HCL 89 77 70 54
EXELON 88 77 71 132
AMLODIPINE BESYLATE-BENAZEPRIL 88 88 71 50
GLIPIZIDE 87 87 73 74
DIVALPROEX SODIUM 87 87 73 119
DILTIAZEM ER 82 69 75 134
FLUOXETINE HCL 82 67 75 65
IPRATROPIUM-ALBUTEROL 81 79 77 214
BENAZEPRIL HCL 75 72 78 59
AMIODARONE HCL 75 75 78 139
NOVOLOG 74 65 80 158
PAROXETINE HCL 74 74 80 69
LEXAPRO 73 63 82 219
ALBUTEROL SULFATE 64 63 83 163
ZETIA 63 63 84 94
RANITIDINE HCL 63 58 84 39
PHENYTOIN SODIUM EXTENDED 61 48 86 128
ROPINIROLE HCL 60 35 87 87
PROMETHAZINE HCL 60 46 R 87 66
TRIAMCINOLONE ACETONIDE 60 57 87 154
IBUPROFEN 60 37 87 93
NYSTOP 57 42 91 424
KLOR-CON M20 57 54 91 57
PREMARIN 57 47 R 91 110
SPIRIVA 56 30 94 72
HUMULIN 70-30 55 38 95 106
LEVETIRACETAM 55 37 95 130
GLIPIZIDE ER 55 43 95 109
ESTRADIOL 55 41 R 95 122
ADVAIR DISKUS 54 42 99 68
OXYCONTIN 54 35 S2 99 165
ACTOS 53 46 101 144
VENLAFAXINE HCL ER 53 32 101 117
THEOPHYLLINE ANHYDROUS 53 41 101 185
FOSINOPRIL SODIUM 53 53 101 112
LEVEMIR 52 38 105 198
DETROL LA 52 36 105 215
BUPROPION XL 51 45 107 177
TERAZOSIN HCL 51 51 107 160
FINASTERIDE 51 30 107 150
CLOTRIMAZOLE-BETAMETHASONE 51 24 107 166
DILTIAZEM 24HR CD 50 38 111 138
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 9, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.